Portfolio Company · Operating Co.

Linnaeus Group

Healthcare & Pharma Services

backed bySovereign Capital

ExitedHealthcare & Pharma Services

Linnaeus Group

a portfolio company of

Sovereign Capital

Status on record: Exited

Investment year: 2014

PE Firm Index

Who owns Linnaeus Group?

Linnaeus Group is listed as an exited portfolio company of Sovereign Capital on Sovereign Capital's own portfolio page. Sovereign Capital invested in Linnaeus Group in 2014, per Sovereign Capital's portfolio page.

Company Snapshot

Linnaeus Group is a Healthcare & Pharma Services company. Its owner on record, Sovereign Capital, is a buy & build firm. Sovereign Capital lists 40 companies in the index, 11 of them in Healthcare & Pharma Services.

SectorHealthcare & Pharma Services

Parent PE firmSovereign Capital

Ownership statusExited

WebsiteNot on record

About the owner

Sovereign Capital

Strategy: Buy & Build, Strategic acquisition, Leadership transformation, Strategic consolidation, MBO, Business succession
Sectors: Business & Technology Services, Education & Training, Financial & Professional Services
Companies in the index: 40

Sovereign Capital Partners is a UK mid-market private equity firm that specialises in Buy and Build strategies for service-based businesses.

Read the Sovereign Capital profile

Questions about Linnaeus Group

Who owns Linnaeus Group?

What sector is Linnaeus Group in?

Linnaeus Group is in Healthcare & Pharma Services. Classified from the owner's portfolio label.

What else does Sovereign Capital own in Healthcare & Pharma Services?

Sovereign Capital lists 10 other Healthcare & Pharma Services companies in the index, including Bioscript, Choice Care Group, Christchurch Group, City & County Healthcare and Complete Group.

Sources

Sovereign Capital
https://www.sovereigncapital.co.uk/our-investments

This profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with Linnaeus Group and does not provide investment advice.

Other portfolio companies of Sovereign Capital

6 of 39 shown

8 Solutions

Business & Technology Services

Acolin

Business & Technology Services

Actica

Business & Technology Services

Affinia

Financial & Professional Services

Agena Group

Business & Technology Services

Alcumus

Business & Technology Services

See the full Sovereign Capital portfolio.

Other Healthcare & Pharma Services companies held by Sovereign Capital

Bioscript Choice Care Group Christchurch Group City & County Healthcare Complete Group CVS Group

Other Healthcare & Pharma Services portfolio companies

via Wavemaker 360 Health

3P Biopharmaceuticals

via Marlin Equity Partners

Browse PE-backed companies.

Is this your company?

Claiming is free and reviewed by hand. Correct facts and add your team.

Claim this profile Suggest a correction

Ownership

Parent PE firm

Sovereign Capital

Status: Exited

Investment year: 2014

For PE-backed companies

DevriX

DevriX runs the websites, integrations and data that bring in revenue, as one accountable engineering and operations team, through acquisitions and exit.

Where DevriX helps

Value creation through the holdRevenue, data, web and AI run as one operating cadence, tied to EBITDA.Add-ons and carve-outsConsolidate or separate platforms and unify reporting after a deal.Exit readinessFind the technology and data issues a buyer's diligence would raise, before it does.

Send DevriX a short brief

A short form on devrix.com. No call to book.

Disclosure: PE Firm Index is maintained by Mario Peshev, who founded and runs DevriX. DevriX listing

Weekly PE M&A and market research, by email

The Growth Shuttle Insider is Mario Peshev's weekly newsletter for PE owners and operators. Each issue carries the week's private equity deals from this index, market data and research, and an essay from Mario.

Free. One email a week. Unsubscribe from any issue. Your address goes to beehiiv, the service that sends the Insider.

Research

The 2027 Digital Value Creation Baseline

1,407 PE-backed companies from 179 sponsors, measured from public sources in October 2026. 15% of service and product companies have the full path from search to CRM.

Read the research

Research by Growth Shuttle and DevriX.